Clinical trial · Observational
Development and Demonstration of Intelligent Assessment Based on Multi-modal Information Fusion for Tumor Risk and Diagnosis and Treatment
NCT06653478CI-TRIAL-00081809recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To improve the accuracy of risk prediction, screening and treatment outcome of cancer, we aim to establish a medical database that includes standardized and structured clinical diagnosis and treatment information, image features, pathological features, and multi-omics information and to develop a multi-modal data fusion-based technology system using artificial intelligence technology based on database.
Conditions
Conditions (9)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Artificial Intelligence | — | UNRESOLVED | — |
| Cancer Risk | — | UNRESOLVED | — |
| Cancer Screening | — | UNRESOLVED | — |
| Cancer, Treatment-Related | Malignant Neoplasm | ALIAS | 0.85 |
| Colon Cancer | Malignant Colon Neoplasm | CURATED_EXACT | 0.92 |
| Deep Learning | — | UNRESOLVED | — |
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
| Lung; Node | — | UNRESOLVED | — |
| Stomach Cancer | Malignant Gastric Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| No Intervention | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- label
- Lung cancer group
- description
- Participants with lung cancer/pulmonary nodules
- interventionNames
- Other: No Intervention
- label
- Stomach cancer group
- description
- Participants with Stomach cancer/Stomach lesion
- interventionNames
- Other: No Intervention
- label
- Colorectal cancer group
- description
- Participants with Colorectal cancer/Colorectal lesion
- interventionNames
- Other: No Intervention
Primary outcomes (3)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: 1. Participants with the suspected of lung cancer/node, or stomach cancer/lesion, or colorectal cancer/leision 2. Participants that have signed informed consent. 3. Participants with detailed electronic medical records, image records, pathological records, multi-omics information, and other important clinical diagnostic information. 4. Healthy participants with no clinical diagnosis of lung cancer/node, or stomach cancer/lesion, or colorectal cancer/leision. Exclusion Criteria: 1. Participants with primary clinical and pathological data missing. 2. Participants lost to follow-up. 3. Participants with too poor medical image quality to perform segment and mark ROI accurately
References
Publications (0)
Data not yet available
No reference posted for this study.